Author

Hongyang Deng

Institutions: Lanzhou University Second Hospital, Lanzhou University

Observed institutions: Lanzhou University Second Hospital, Lanzhou University

ORCID: 0000-0002-3028-7378

Observed ORCID: 0000-0002-3028-7378

OpenAlex ID: A5063849709

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect

2023 · Hongyang Deng, Jiaxing Zhang, et al. · Cancers · 28

CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

2022 · Hongyang Deng, Jiaxing Zhang, et al. · Frontiers in Surgery · 13

High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer

2023 · Hongyang Deng, Tengfei Li, et al. · Pathology & Oncology Research · 11

The complex role and molecular mechanism of family with sequence similarity genes in cancer: a comprehensive review

2025 · Hongyang Deng, Xiaodong Xu, et al. · Discover Oncology · 5

Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

2023 · Hongyang Deng, Jiaxing Zhang, et al. · Frontiers in Surgery · 1

GLIS3 drives epithelial–mesenchymal transition and cancer stem–like traits in stomach adenocarcinoma via TGFBR3–Hedgehog signaling

2026 · Qi Xiao, Hongyang Deng, et al. · Frontiers in Oncology

TRIP13 as a prognostic marker and its correlation with clinicopathological features in human cancers: a meta-analysis

2022 · Jipin Li, Hongyang Deng, et al. · Research Square

Works count: 7

Citation count: 58

H-index: 4

I10-index: 3